CRSP Research and Charts

CRSP - CRISPR Therapeutics AG (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-02 (Delayed quote data 2025-09-16)

Last 61.19	Change ⇑ +3.35 (+5.79%)	Volume 4,618,396
	Open 57.89	High 62.07	Low 56.53

8EMA (Daily) 56.50	40EMA (Daily) 54.75	50EMA (Daily) 54.10	STO (Daily) 79.425	MACD Hist (Daily) 1.460
8EMA (Weekly) 56.405	40EMA (Weekly) 49.73	50EMA (Weekly) 49.55	STO (Weekly) 54.473	MACD Hist (Weekly) 1.053


Company Profile
CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.